Stage 2 · Toolkit 2.5
Genetic Toxicology Program
Plan, track, and interpret genotoxicity study results.
What it helps control
Operational support
Helps teams establish the procedures, working records, trackers, and evidence needed for Genetic Toxicology Program.
How it helps your team
Surface evidence gaps and dependencies before they delay IND, CTA, or first-in-human decisions.
Designed for
Nonclinical development, toxicology, safety pharmacology, bioanalysis, Regulatory Affairs, and Quality teams.
Included files
Know exactly what the toolkit contains
The file names below show what is included. File contents become available only after purchase.
Word documents
- Genetic Toxicology Strategy Plan
- Genotoxicity Study Protocol Template
- Genotoxicity Report Review Checklist
- Genotoxicity Interpretation Memo
- Genotoxicity Key Finding Summary
- Genotoxicity Regulatory Impact Memo
Excel workbooks
- Genotoxicity Study Tracker
- Genotoxicity Findings Tracker
- Assay Result Summary Matrix
- Genotoxicity Evidence Matrix
- Source Data Reference Log
Related toolkits
Continue within stage 2
Nonclinical Development Plan & IND/CTA-Enabling Strategy
Define the nonclinical package needed to support IND, CTA, first-in-human, and clinical development.
2.2GLP Compliance & Sponsor Oversight
Ensure GLP studies are appropriately planned, overseen, monitored, documented, reported, and archived.
2.3Toxicology Study Planning & Management
Manage toxicology studies and interpret key findings for regulatory and FIH readiness.